Gimv
Growth equityAntwerp · Growth–Late Stage · 11 people tracked
Investment thesis
Gimv invests in innovation and entrepreneurship, backing entrepreneurial and innovative companies through four strategic investment platforms shaped by societal trends: digitalisation & automation, electrification & energy efficiency, sustainable food & wellbeing, and healthcare. Its approach is built on a solid balance sheet, patient capital and a long-term view, aiming for sustainable value creation by partnering closely with ambitious management teams. As a recognized European market leader, Gimv manages a portfolio of around 60 companies representing roughly EUR 5 billion in combined turnover and more than 20,000 employees.
Source: firm website, verified Aug 3, 2026.
Team · 11 people
from public directoriesWhat they invest in
from 6 of 9 portfolio companiesBiotech ×4Healthtech ×3Medical Devices ×2Advanced Manufacturing ×1Energy ×1Hardware ×1Mobility & Transportation ×1
HQs:Germany×2Netherlands×1United States×1
Investments · 9 tracked
founders shown can be your intro pathTopas Therapeutics develops nanoparticle-based therapies to induce immune tolerance for autoimmune and immune-mediated diseases.
BiotechHealthtech
Hugo Fry(Chief Executive Officer)Christian Schröter(Chief Operating Officer)Cristina de Min(Chief Medical Officer)Anne Burger(Chief Financial Officer)Alex Marshall(Chief Business Officer)
Co-investorsEMBL VenturesBoehringer Ingelheim Venture FundBioMedPartnersEpidarex Capital
BioConnection is a contract manufacturing organization (CMO) providing aseptic fill & finish services and freeze-drying (lyophilization) for sterile pharmaceutical drug products at clinical and commercial scale.
Advanced ManufacturingBiotechMedical Devices
Co-investorsBOM
ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.
BiotechHealthtech
Co-investorsAndera PartnersKurma PartnersPfizer Venture InvestmentsPureos BioventuresAgent Capital
Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.
BiotechHealthtechMedfield, US
Roger Heerman(Chief Business/Operating Officer / Co-Founder)Frazer Morgan(Chief Development Officer / Co-Founder)Robert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)
BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)
Co-investors5AM VenturesAtlas VentureRA CapitalEQT Life SciencesSixty Degree CapitalVivo Capital+1 more
SBS (Smart Battery Solutions) is a German manufacturer that develops, produces, and services lithium-ion batteries, covering the full product life cycle for various industries and applications such as warehouse robotics, industrial drones, rehab technology, light mobility, e-scooters, e-watercraft, e-bikes, and e-cargo.
EnergyHardwareMobility & Transportation
Exits · 1
IPOs and acquisitions across the tracked portfolioImcheckacq. by Clementia
Portfolio news
latest coverage across their companiesKinaset Therapeutics · finsmes.com · Jan 12, 2026
Frequently asked questions
- How many investments has Gimv made?
- Gimv has 5 tracked investments.
- What stage does Gimv invest at?
- Gimv invests at the Growth, Late Stage stages.
- What is Gimv's typical check size?
- Gimv typically writes checks of $21M – $430M.
- What sectors does Gimv focus on?
- Gimv focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Consumer, Data & Infrastructure, Energy, FoodTech, Hardware, Healthtech, Medical Devices, New Materials, SaaS, Semiconductors, Wellness & Fitness.
- Where is Gimv located?
- Gimv is headquartered in Antwerp, BE.
- Does Gimv lead rounds?
- Yes, Gimv leads investment rounds.
Images
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.
Horizon Technology Finance is a specialty finance company providing structured debt to technology and other venture-backed companies.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Mitsui Global Investment is an investment firm that provides capital and hands-on support to entrepreneurs, helping innovative teams scale their businesses onto the global stage.
















